Plicit Capital Corp Share Price Toronto S.E.
Equities
PLPh
CA7291431079
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
15/05 | Telo Genomics Corp. Signs Collaboration Agreement with Emery Pharma | CI |
10/04 | Telo Genomics Receives Accreditation from College of American Pathologists | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.1Cr 0 174.94Cr |
---|---|---|---|---|---|
Net income 2022 | -20L - -17Cr | Net income 2023 | -20L - -17Cr | EV / Sales 2022 | - |
Net cash position 2022 | 26.53L 0 22Cr | Net cash position 2023 | 26.41L 0 22Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-9.95
x | P/E ratio 2023 |
-6.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.01% |
Managers | Title | Age | Since |
---|---|---|---|
Kris Weinberg
CEO | Chief Executive Officer | - | 12/22/12 |
Sherif Louis
PSD | President | - | 01/15/01 |
Christopher Ross
DFI | Director of Finance/CFO | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Meekison
BRD | Director/Board Member | 58 | 01/18/01 |
Director/Board Member | - | 03/22/03 | |
Guido Baechler
CHM | Chairman | 59 | 28/19/28 |
1st Jan change | Capi. | |
---|---|---|
-29.78% | 958.63Cr | |
-2.96% | 321.1Cr | |
+28.23% | 291.87Cr | |
-14.73% | 215.12Cr | |
-15.05% | 178.89Cr | |
+69.62% | 147.44Cr | |
+23.08% | 77Cr | |
-2.84% | 76Cr | |
-24.08% | 55Cr |
- Stock Market
- Equities
- TELO Stock
- PLPh Stock